Skip to main content
. Author manuscript; available in PMC: 2019 Jun 15.
Published in final edited form as: Cancer. 2018 May 6;124(12):2629–2636. doi: 10.1002/cncr.31330

Table 2.

Means and standard deviations for health-related quality of life and psychological symptom burden measures

Domain Measure N Range Sample
Mean (SD)
Adult cancer patients
Mean (SD)
Metastatic breast cancer
Mean (SD)
Health-related quality of life Functional Assessment of Cancer Therapy-General 223 25–107 65.5 (16.4) 79.3 (17.0) 81.9 (14.3)
 Physical well-being 224 3–28 18.4 (6.1) 21.0 (6.0)
 Social/family well-being 224 5–28 17.8 (5.4) 22.0 (5.3)
 Emotional well-being 223 0–23 13.1 (5.0) 18.1 (4.6)
 Functional well-being 223 2–28 16.1 (5.4) 18.2 (6.6)
Anxiety symptom severity PROMIS Anxiety* 210 37–83 56.0 (9.8)
Depression symptom severity PROMIS Depression* 210 38–81 56.0 (8.3)
Parenting concerns Parenting Concerns Questionnaire 211 1–5 2.2 (0.7)
 Practical concerns 211 1–5 2.3 (0.9)
 Emotional concerns 210 1–5 2.2 (0.9)
 Concerns about co-parent 206 1–5 2.1 (1.1)
*

T score normed to population

Adult cancer patient sample, all disease types, n=4912; Pearman et al, Ambulatory Cancer and US General Population References Values and Cutoff Scores for the Functional Assessment of Cancer Therapy. Cancer 2014;(120), p2906.20

Adult metastatic breast cancer patient sample, n=187; Pearman et al, Ambulatory Cancer and US General Population References Values and Cutoff Scores for the Functional Assessment of Cancer Therapy. Cancer 2014;(120), online supplement.20

Abbreviations: PROMIS=Patient-Reported Outcomes Measurement Information System (range 0–100, higher scores indicate more symptoms, 50=US general population mean);